Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Value of 11C-methionine PET in imaging brain tumours and metastases

AWJM Glaudemans, RH Enting… - European journal of …, 2013 - Springer
Abstract 11 C-methionine (MET) is the most popular amino acid tracer used in PET imaging
of brain tumours. Because of its characteristics, MET PET provides a high detection rate of …

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …

Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies

N Verma, MC Cowperthwaite, MG Burnett… - Neuro …, 2013 - academic.oup.com
Differentiating treatment-induced necrosis from tumor recurrence is a central challenge in
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …

Molecular imaging of gliomas with PET: opportunities and limitations

C la Fougere, B Suchorska, P Bartenstein… - Neuro …, 2011 - academic.oup.com
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of
the key factors for individualized therapy and patient management, since accurate diagnosis …

The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma

N Galldiks, G Stoffels, C Filss, M Rapp, T Blau… - Neuro …, 2015 - academic.oup.com
Background We evaluated the diagnostic value of static and dynamic O-(2-[18F] fluoroethyl)-
l-tyrosine (18F-FET) PET parameters in patients with progressive or recurrent glioma …

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading

G Pöpperl, FW Kreth, JH Mehrkens, J Herms… - European journal of …, 2007 - Springer
Purpose Treatment and prognosis of gliomas depend on their histological tumour grade.
The aim of the study was to evaluate the potential of [18 F] fluoroethyltyrosine (FET) PET for …

Tumor cell metabolism imaging

C Plathow, WA Weber - Journal of Nuclear Medicine, 2008 - jnm.snmjournals.org
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy–detecting illusive disease, defining response

RY Huang, MR Neagu, DA Reardon, PY Wen - Frontiers in neurology, 2015 - frontiersin.org
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating
diagnosis with an average survival of 14–16 months using the current standard of care …

Brain tumors

K Herholz, KJ Langen, C Schiepers… - Seminars in nuclear …, 2012 - Elsevier
This review addresses the specific contributions of nuclear medicine techniques, and
especially positron emission tomography (PET), for diagnosis and management of brain …